4.6(top 3%)
Impact Factor
5.2(top 3%)
extended IF
35(top 11%)
H-Index
410
authors
327
papers
4.5K
citations
692
citing journals
3.1K
citing authors

Most Cited Articles of Lupus Science and Medicine

TitleYearCitations
Haematological manifestations of lupus2015111
Effect of corticosteroid use by dose on the risk of developing organ damage over time in systemic lupus erythematosus-the Hopkins Lupus Cohort201586
A proteinuria cut-off level of 0.7 g/day after 12 months of treatment best predicts long-term renal outcome in lupus nephritis: data from the MAINTAIN Nephritis Trial201586
Interferon pathway in SLE: one key to unlocking the mystery of the disease201985
Thank you to our reviewers 2017201878
Outcomes in mothers with rheumatic diseases and their offspring workshop201778
Response to belimumab among patients with systemic lupus erythematosus in clinical practice settings: 24-month results from the OBSErve study in the USA201672
Lupus anticoagulant is the main predictor of adverse pregnancy outcomes in aPL-positive patients: validation of PROMISSE study results201672
Association of the interferon signature metric with serological disease manifestations but not global activity scores in multiple cohorts of patients with SLE201566
Role of early repeated renal biopsies in lupus nephritis201466
DNA methylation patterns in naïve CD4+ T cells identify epigenetic susceptibility loci for malar rash and discoid rash in systemic lupus erythematosus201565
Mouse models of lupus: what they tell us and what they don't201861
Current and future therapies for SLE: obstacles and recommendations for the development of novel treatments201760
Placental histology and neutrophil extracellular traps in lupus and pre-eclampsia pregnancies201660
Type I interferons in host defence and inflammatory diseases201954
Cell-bound complement activation products in systemic lupus erythematosus: comparison with anti-double-stranded DNA and standard complement measurements201454
Early proteinuria response: a valid real-life situation predictor of long-term lupus renal outcome in an ethnically diverse group with severe biopsy-proven nephritis?201753
Clinical, laboratory and health-related quality of life correlates of Systemic Lupus Erythematosus Responder Index response: a post hoc analysis of the phase 3 belimumab trials201453
Independent association of glucocorticoids with damage accrual in SLE201653
Association of low vitamin D with high disease activity in an Australian systemic lupus erythematosus cohort201545
Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosus201845
Inducible T-cell co-stimulator ligand (ICOSL) blockade leads to selective inhibition of anti-KLH IgG responses in subjects with systemic lupus erythematosus201645
Lupus community panel proposals for optimising clinical trials: 2018201843
Risk factors for osteoporosis and fragility fractures in patients with systemic lupus erythematosus201643
Systemic lupus erythematosus complicated by diffuse alveolar haemorrhage: risk factors, therapy and survival201540